Heart & Lung: The Journal of Acute and Critical Care
Volume 35, Issue 3 , Pages 170-177 , May 2006

Relation of atrial arrhythmia-related symptoms to health-related quality of life in patients with newly diagnosed atrial fibrillation: A community hospital-based cohort

  • Younhee Kang, RN, MSN-ANP, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Younhee Kang, RN, MSN-ANP, PhD, 11-1 Daehyun-dong, Seodaemun-gu, College of Nursing Science, Ewha Womans University, Seoul 120-750, South Korea.

References 

  1. Coumel P . Autonomic influences in atrial tachyarrhythmias . J Cardiovasc Electrophysiol . 1996;7:999–1007
  2. Jung W , Luderitz B . Quality of life in patients with atrial fibrillation . J Cardiovasc Electrophysiol . 1998;9: S177-S187
  3. Furberg CD , Psaty BM , Manolio TA , et al.   Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study) . Am J Cardiol . 1994;74:236–241
  4. Psaty BM , Manolio TA , Kuller TM , et al.   Incidence of and risk factors for atrial fibrillation in older adults . Circulation . 1997;96:2455–2461
  5. Kannel WB , Abbott RD , Savage DD , McNamara PM . Epidemiologic features of chronic atrial fibrillation (The Framingham study) . N Engl J Med . 1982;306:1018–1022
  6. Stewart S , Hart CL , Hole DA , McMurray JJV . Population prevalence, incidence and predictors of atrial fibrillation in the Renfrew/Paisley study . Heart . 2001;86:516–521
  7. Tanigawa M , Fukatani M , Konoe A , Isomoto S , Kadena M , Hashiba K . Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sick sinus node syndrome . J Am Coll Cardiol . 1991;17:403–408
  8. Bialy D , Lehmann MH , Schumacher DN . Hospitalization for arrhythmia in the United States (importance of atrial fibrillation [abstract]) . J Am Coll Cardiol . 1992;19:41
  9. Golzari H , Cebul RD , Bahler RC . Atrial fibrillation (restoration and maintenance of sinus rhythm and indicators for anticoagulation therapy) . Ann Intern Med . 1996;125:311–323
  10. Singh BN . Atrial fibrillation (epidemiologic considerations and rationale for conversion and maintenance of sinus rhythm) . J Cardiovasc Pharmacol Ther . 2003;8:S13–S26
  11. Davidson P , Rees DM , Brighton TA , et al.   Non-valvular atrial fibrillation and stroke (implications for nursing practice and therapeutics) . Aust Crit Care . 2004;17:65–73
  12. Fumeaux T , Cornuz J , Polikar R , et al.   Guidelines for the clinical management of atrial fibrillation (a practical perspective) . Swiss Med Wkly . 2004;1:235–247
  13. Brignole M , Bianfranchi L , Menozzi C . Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance . Am J Cardiol . 1994;74:242–246
  14. Bubien RS , Knotts-Dolson SM , Plumb VJ . Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias . Circulation . 1996;94:1585–1591
  15. Kay GN , Bubien RS , Epstein AE . Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation . Am J Cardiol . 1988;62:741–744
  16. Olgin JE , Scheinman MM . Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction . J Am Coll Cardiol . 1993;21:557–564
  17. Rosenqvist M , Lee MA , Moulinier L . Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction . J Am Coll Cardiol . 1990;16:1467–1474
  18. World Health Organization . WHOQOL Study Protocol (the development of the World Health Organization Quality of Life assessment instrument) . Publication MNH/PSF/93.9 . Geneva, Switzerland: Division of Mental Health, World Health Organization; 1993;
  19. Jenkins LS , Bubien RS . Quality of life in patients with atrial fibrillation . Cardiol Clin . 1996;14:597–606
  20. Anderson JL , et al.   Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy . Circulation . 1989;80:1557–1570
  21. Bhandari AK , Anderson JL , Gilbert EM , et al.   Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation (a transtelephonic monitoring study) . Am Heart J . 1992;124:381–386
  22. Hamer ME , Blumenthal JA , McCarthy EA , et al.   Quality of life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia . Am J Cardiol . 1994;74:826–829
  23. Bubien RS , Kay GN , Jenkins LS . Test specifications for Symptom Checklist (Frequency and Severity) . Milwaukee: University of Wisconsin-Milwaukee; 1993;
  24. Jenkins LS . The manual for the Symptom Checklists-Frequency and Severity . Maryland: University of Maryland; 1993;
  25. Ware JE , Kosinski M , Keller SK . SF-36 physical and mental health summary scales (a user’s manual) . Boston: New England Medical Center; 1994;
  26. Ware JE , Keller S , Bentler PM , Sullivan M , Brazier J , Gandek B . Comparisons of health status measurement models and the validity of SF-36 in Great Britain, Sweden and the USA . Qual Life Res . 1994;3:68
  27. McHorney CA , Ware JE , Raczek AE . The MOS 36-Item Short-Form Health Survey (SF-36): II. psychometric and clinical tests of validity in measuring physical and mental health constructs . Med Care . 1993;31:247–263
  28. Sullivan M , Karlsson J , Ware JE . SF-36 HSlsoenkSt (Svensk Manual Och Tolkningsguide (Swedish Manual and Interpretation Guide)) . Gothenburg: Sahlgrenska University Hospital; 1994;
  29. McCallum J . The SF-36 in an Australian sample (validating a new, generic health status measure) . Aust J Public Health . 1995;19(2):160–166
  30. Shadbolt B , McCallum J , Singh M . Health outcomes by self-report (validity of the SF-36 among Australian hospital patients) . Qual Life Res . 1997;6(4):343–352
  31. Carroll DL , Hamilton GA , McGovern BA . Changes in health status and quality of life and the impact of uncertainty in patients who survive life-threatening arrhythmias . Heart Lung . 1999;28:251–260
  32. Ware JE , Snow KK , Kosinski M , Gandek B . SF-36 Health Survey Manual and Interpretation Guide . Boston: New England Medical Center, The Health Institute; 1993;
  33. Ware JE , Kosinski M , Bayliss MS , McHorney CA , Rogers WH , Raczek A . Comparison of methods for scoring and statistical analysis of SF-36 health profiles and summary measures (summary of results from the Medical Outcomes Study) . Med Care . 1995;33(Suppl 4): AS264-AS79
  34. Charlson ME , Pompei P , Ales KL , MacKenzie CR . A new method of classifying prognostic comorbidity in longitudinal studies (development and validation) . J Chron Dis . 1987;40:373–383
  35. Perkins AJ , Kroenke K , Unutzer J , et al.   Common comorbidity scales were similar in their ability to predict health care costs and mortality . J Clin Epidemiol . 2004;57:1040–1048
  36. Deyo RA , Cherkin DC , Ciol MA . Adapting a clinical comorbidity index for use with ICD-9-CM administrative database . J Clin Epidemiol . 1992;45:613–619
  37. Schneeweiss S , Seeger JD , Maclure M , Wang PS , Avorn J , Glynn RJ . Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data . Am J Epidemiol . 2001;154:854–864
  38. Cohen J . Statistical power analysis for the behavioral sciences . 2nd ed.. Hillsdale: Lawrence Erlbaum Associates, Publishers; 1988;

PII: S0147-9563(06)00031-8

doi: 10.1016/j.hrtlng.2006.01.002

Heart & Lung: The Journal of Acute and Critical Care
Volume 35, Issue 3 , Pages 170-177 , May 2006

Article Tools